Management of chronic hepatitis b_ experience from china – sun – 2010 – journal of viral hepatitis – wiley online library

Prof. Cure for hep b carrier Jinlin Hou, Hepatology Unit and Key Lab for Organ Failure Research, Nanfang Hospital, Southern Medical University, No.1838, Guangzhou Dadaobei, Guangzhou 510515, China. Hepatitis c vaccine cost E-mail:

Summary. Hepatitis c symptoms treatment Chronic hepatitis B infection is a significant health problem throughout the world, and particularly in China. Hepatitis type c It is estimated that more than half a million Chinese people die annually from end-stage hepatitis B complications, which is associated with huge healthcare costs and a heavy socioeconomic burden.

Q es hepatitis c In China, the implementation of a hepatitis B vaccination programme has come into effect, and there has been a one-third decrease of the hepatitis B virus (HBV) carrier population since 1992. What is hepatitis c symptoms This great achievement changes China from a highly endemic area for HBV infection to an intermediate one. Hepatitis c awareness The predominant HBV genotypes in China are B and C, which might predispose patients to a poor antiviral response. Hepatitis b and c Patients and physicians from China have been actively involved in the global research into and development of new antiviral agents. Genotype 3 hepatitis c treatment Patients have been recruited for global and domestic clinical trials on antiviral agents, including lamivudine, adefovir dipivoxil, entecavir, telbivudine and two pegylated interferon- . Cure to hepatitis c In the future, more important data, focussing on optimization of the efficacy of antiviral agents, will be released from China, based on the newly launched National Eleven Five Plan Project on Hepatitis Research. Hepatitis c statistics Both economic development and healthcare system reform, including a new reimbursement policy, will make antiviral agents more accessible to Chinese patients. Causes hepatitis c Ultimately, this will allow physicians greater opportunities to follow international and Chinese treatment recommendations.

• 1 Lai Wei, Jia-Horng Kao, Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naive patients with chronic hepatitis B, Current Medical Research and Opinion, 2017, 33, 3, 495 CrossRef

• 2 Florian Bert, Andreas Rindermann, Murad A. The cause of hepatitis c Abdelfattah, Jona T. How can hepatitis c be transmitted Stahmeyer, Siegbert Rossol, High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area, European Journal of Gastroenterology & Hepatology, 2016, 28, 11, 1246 CrossRef

• 3 Chuoji Huang, Hui Heng Lin, Jian-bo Wan, Chengwei He, Yuanjia Hu, Jinn-Moon Yang, Research and Development of Hepatitis B Drugs: An Analysis Based on Technology Flows Measured by Patent Citations, PLOS ONE, 2016, 11, 10, e0164328 CrossRef

• 4 Xin Zheng, Junzhong Wang, Dongliang Yang, Antiviral therapy for chronic hepatitis B in China, Medical Microbiology and Immunology, 2015, 204, 1, 115 CrossRef

• 5 Feifei Wei, Yakun Lang, Dandan Gong, Yu Fan, Effect of Dahuang zhechong formula on liver fibrosis in patients with chronic hepatitis B: A meta-analysis, Complementary Therapies in Medicine, 2015, 23, 1, 129 CrossRef

• 6 Jingjing Tao, Kunkai Su, Chengbo Yu, Xiaoli Liu, Wei Wu, Wei Xu, Bingxun Jiang, Rui Luo, Jian Yao, Jiawei Zhou, Yan Zhan, Chao Ye, Wenji Yuan, Xianzhong Jiang, Wenyan Cui, Ming D. Can you get hepatitis c from drinking after someone Li, Lianjuan Li, Fine mapping analysis of HLA-DP/DQ gene clusters on chromosome 6 reveals multiple susceptibility loci for HBV infection, Amino Acids, 2015, 47, 12, 2623 CrossRef

• 7 Qi Zhang, Yun Liao, Bei Cai, Yi Li, Lixin Li, Junlong Zhang, Yunfei An, Lanlan Wang, Incidence of natural resistance mutations in naive chronic hepatitis B patients: A systematic review and meta-analysis, Journal of Gastroenterology and Hepatology, 2015, 30, 2, 252 Wiley Online Library

• 8 Xinyan Li, Fahong Li, Yao Zhang, Yaoyue Kang, Jie Yu, Feifei Yang, Hongyan Liu, Yanli Qin, Yuxian Huang, Richeng Mao, Jiming Zhang, Partial virological response to entecavir treatment in nucleos(t)ide-naive patients with HBeAg-positive chronic hepatitis B is not caused by reduced sensitivity, Biochemical and Biophysical Research Communications, 2015, 464, 4, 1185 CrossRef

• 9 Xieer Liang, Jun Cheng, Yongtao Sun, Xinyue Chen, Tong Li, Hao Wang, Jianning Jiang, Xiaoping Chen, Hui Long, Hong Tang, Yanyan Yu, Jifang Sheng, Shijun Chen, Junqi Niu, Hong Ren, Junping Shi, Xiaoguang Dou, Mobin Wan, Jiaji Jiang, Qing Xie, Guangfeng Shi, Qin Ning, Chengwei Chen, Deming Tan, Hong Ma, Jian Sun, Jidong Jia, Hui Zhuang, Jinlin Hou, Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients, Journal of Gastroenterology and Hepatology, 2015, 30, 4, 748 Wiley Online Library

• 10 J. What is hepatitis c caused by L. Hiv hepatitis c Hou, Z. What can cause hepatitis c L. Prognosis for hepatitis c Gao, Q. Hepatitis ab and c Xie, J. Hepatitis c treatment medications M. Side effects of hepatitis c Zhang, J. Reasons for hepatitis c F. Is hepatitis c Sheng, J. Symptoms of acute hepatitis c Cheng, C. Hepatitis c patient W. Is hepatitis c virus or bacteria Chen, Q. Hepatitis c pictures Mao, W. Hepatitis virus c Zhao, H. Hepatitis c genotype Ren, D. How is hepatitis c cured M. Hepatitis c Tan, J. Replication of hepatitis c virus Q. Type c hepatitis Niu, S. Hepatitis c treatment naive J. Hepatitis c foundation Chen, C. Hepatitis c precautions Pan, H. Hepatitis c and hiv Tang, H. Genotype 2 hepatitis c treatment Wang, Y. Is hepatitis c transmitted by saliva M. Hepatitis c treatment 2015 Mao, J. Hepatitis c symptoms in men D. Hepatitis c virus ppt Jia, Q. Hepatitis c virus images Ning, M. What is the hepatitis c virus Xu, S. About hepatitis c M. Cure for hepatitis b 2015 Wu, J. How hepatitis c transmitted Li, X. Treatment for hepatitis c genotype 2 X. How common is hepatitis c Zhang, Y. Liver with hepatitis c Ji, J. How do you get hepatitis c virus Dong, J. Hepatitis c and pregnancy Li, Tenofovir disoproxil fumaratevsadefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial, Journal of Viral Hepatitis, 2015, 22, 2, 85 Wiley Online Library

• 11 Min He, Yu Wu, Mengmeng Wang, Wenwen Chen, Weian Yuan, Jian Jiang, The Clinical Value of Oxymatrine in Preventing Lamivudine Induced YMDD Mutation: A Meta-Analysis, Evidence-Based Complementary and Alternative Medicine, 2015, 2015, 1 CrossRef

• 12 Jian Sun, Qing Xie, Deming Tan, Qin Ning, Junqi Niu, Xuefan Bai, Rong Fan, Shijun Chen, Jun Cheng, Yanyan Yu, Hao Wang, Min Xu, Guangfeng Shi, Mobin Wan, Xinyue Chen, Hong Tang, Jifang Sheng, Xiaoguang Dou, Junping Shi, Hong Ren, Maorong Wang, Hongfei Zhang, Zhiliang Gao, Chengwei Chen, Hong Ma, Jidong Jia, Jinlin Hou, The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: A randomized, controlled study, Hepatology, 2014, 59, 4, 1283 Wiley Online Library

• 13 Yun Xia, Hui Luo, Jian Ping Liu, Christian Gluud, Jian Ping Liu, Cochrane Database of Systematic Reviews, 2013 Wiley Online Library

• 14 H. Symptoms hepatitis c You, J. Hepatitis c pregnancy Jia, Telbivudine treatment in chronic hepatitis B: experience from China, Journal of Viral Hepatitis, 2013, 20, 3 Wiley Online Library

• 15 Yun Xia, Mei Han, Jian Ping Liu, Christian Gluud, Yun Xia, Cochrane Database of Systematic Reviews, 2011 Wiley Online Library

• 16 Yun Xia, Hui Luo, Jian Ping Liu, Christian Gluud, Yun Xia, Cochrane Database of Systematic Reviews, 2011 Wiley Online Library

• 17 Yun Xia, Jian Ping Liu, Christian Gluud, Yun Xia, Cochrane Database of Systematic Reviews, 2011 Wiley Online Library

• 18 Yun Xia, Hui Luo, Jian Ping Liu, Christian Gluud, Yun Xia, Cochrane Database of Systematic Reviews, 2011 Wiley Online Library

• 19 Yun Xia, Jian Ping Liu, Christian Gluud, Yun Xia, Cochrane Database of Systematic Reviews, 2011 Wiley Online Library

• 20 Shuangsuo Dang, Ning Gao, Xin Zhang, Xiaoli Jia, Rhabdomyolysis in a 48-Year-Old Man With Hepatitis B-Induced Cirrhosis, The American Journal of the Medical Sciences, 2011, 342, 1, 73 CrossRef

Leave a Reply

Your email address will not be published. Required fields are marked *